Novasenta develops treatments to transform the lives of patients with cancer. It uses systematic, rigorous, and unbiased human tumor microenvironment analysis to uncover new druggable targets, exploiting the critical interplay of disease, immune response, and metabolism. Single-cell level analysis of high-quality, human tumor samples combined withthe advanced data mining abilities of our research and computational biology teams accelerate the path from discovery to patient. The company aims to identify novel targets to generate effective therapies for various cancers. It was founded in 2018 and is headquartered in Pittsburgh, Pennsylvania.

Biotechnology

Health Care

Therapeutics

Novasenta

Mani Mohindru

Ann Tanilli

Michael Lyman

Greg Delgoffe

Jeanne Cunicelli

Matthias Kleinz

The Research and Development Team at Novasenta is responsible for identifying and validating new druggable targets within the human tumor microenvironment. By utilizing single-cell level analysis of high-quality human tumor samples and advanced data mining techniques, the team accelerates the discovery and development of transformative cancer therapies. This group of scientists, associates, and technicians collaborates to explore the interplay of disease, immune response, and metabolism, driving the path from scientific discovery to effective patient treatments.

Research and Development Team

The Board and Founders at Novasenta oversee the strategic direction and governance of the company. They utilize their expertise and leadership to guide the development of innovative cancer treatments, ensure compliance with ethical standards, and drive company growth. By collaborating closely with research and development teams, they help translate scientific discoveries into effective therapies for patients.

Board and Founders

The Leadership Team at Novasenta is responsible for setting the strategic direction of the company, ensuring the alignment of research and development efforts with the company's mission to develop transformative cancer treatments. They provide visionary guidance, oversee major operational and organizational decisions, and foster a culture of innovation and collaboration to accelerate the identification and development of novel therapeutic targets.

Leadership Team

The Research and Development team at Novasenta is responsible for identifying novel drug targets within the human tumor microenvironment through rigorous single-cell level analysis. Leveraging advanced data mining and computational biology, they accelerate the discovery and development of new antibody therapeutics with the goal of generating effective treatments for various cancers.

Research and Development

The Computational and Translational Sciences team at Novasenta focuses on integrating cutting-edge computational biology with advanced translational research to identify novel druggable targets in cancer. By analyzing single-cell level data from high-quality human tumor samples, this team exploits the interplay between disease, immune response, and metabolism to accelerate the discovery and development of transformative cancer therapies.

Novasenta

Org chart

Board & advisors

Teams

Research and Development Team

Board and Founders

Leadership Team

Research and Development

Computational and Translational Sciences

Offices

Novasenta

Org chart

Board & advisors

Teams

Research and Development Team

Board and Founders

Leadership Team

Research and Development

Computational and Translational Sciences

Offices

Related companies